John Charbonneau
Vice President, Investor Relations
Replay available
Core Scientific, Inc. (NASDAQ: CORZ) Q4 2024 earnings conference call, held 2025-02-26. Replay captured from the company's public earnings webcast.

Vice President, Investor Relations
CEO
CFO
Roth Capital Partners
Jefferies
Cantor Fitzgerald
BTIG
Craig Hallam
Jones Trading
HC Wainwright
B Reilly
Canaccord Genuity
Steeple
Odeon Capital
Greetings, and welcome to the Core Scientific Fourth Quarter Fiscal Year 2024 Earnings Conference Call. At this time, all participants are in listen-only mode. If anyone should require operator assistance, please press star zero on your telephone keypad. A question and answer session will follow the following presentation. You may be placed in the question queue at any time by pressing star one on your telephone keypad, and we ask you to please limit yourselves to one question and one follow-up. As a reminder, this conference is being recorded for replay purposes. It's now my pleasure to turn it over to John Charbonneau, Vice President, Investor Relations at Core Scientific. John, please go ahead. Good afternoon, ladies and gentlemen, and welcome to Core Scientific's fourth quarter fiscal year 2024 earnings call. At this time, all participants are in a listen-only mode. We'll conduct a question and answer session after management's remarks. Please note that on this call, certain information presented contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement other than historical or current facts that predict or indicate future events or trends, forecasts, performance or achievements, and may contain words such as believe, anticipate, expect, estimate, intend, project, plan or words or phrases with similar meaning. Forward-looking statements are based on current expectations, forecasts and assumptions that involve risks and uncertainties that may cause actual results to differ materially. For further information on these risks and uncertainties, we encourage you to review the risk factors discussed in the company's a...